DEREK LAFONT: Open Payments
NPI 1013980184 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,257 in 184 payments from 47 companies in 2025. Trend: 2023 $6,355 · 2024 $6,747 · 2025 $5,257
Food & beverage: $3,541Long term medical supply or device loan: $1,000Education: $636Travel & lodging: $80
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 26 | $1,350 |
| Daiichi Sankyo Inc. | 14 | $380 |
| AstraZeneca Pharmaceuticals LP | 12 | $274 |
| PFIZER INC. | 11 | $273 |
| Janssen Biotech, Inc. | 9 | $262 |
| Astellas Pharma US Inc | 7 | $237 |
| Gilead Sciences, Inc. | 7 | $234 |
| E.R. Squibb & Sons, L.L.C. | 11 | $185 |
| Incyte Corporation | 3 | $177 |
| BeOne Medicines USA, Inc. | 7 | $137 |
Products named: KISQALI, ENHERTU, Trodelvy, IBRANCE, DARZALEX, Jakafi, OPDIVO, KEYTRUDA.
Industry payments across GA — which companies pay providers there.
